Analyze Diet
Neuroendocrinology1991; 53(3); 214-221; doi: 10.1159/000125721

Characterization and mapping of melatonin receptors in the brain of three mammalian species: rabbit, horse and sheep. A comparative in vitro binding study.

Abstract: Melatonin receptors were characterized in the brains of three mammals (rabbit, horse and sheep) by an in vitro binding technique, using 2-[125I]iodomelatonin as labelled ligand. Although binding sites for melatonin have been described recently in several vertebrate species (including the sheep), the rabbit and the horse have not been the subject of investigation so far. Apart from characterization, the present report describes receptor distribution in a number of brain regions, thus allowing for direct interspecies comparison under the same methodological conditions. 2-[125I]iodomelatonin labelled high-affinity binding sites in crude membrane preparations from these species. A series of kinetic and saturation experiments revealed that the binding was rapid, stable, saturable, reversible, of high affinity (Kd in the low picomolar range) and low capacity (Bmax between 1 and 20 fmol/mg protein). The competition studies showed that the relative order of potency of a variety of indoles for inhibition of 2-[125I]iodomelatonin binding was as follows: 2-iodomelatonin greater than 6-chloromelatonin greater than melatonin much much greater than 5-methoxytryptophol greater than 5-methoxytryptamine, and that it was similar in the different brain regions. Prazosin, which has been reported as an extremely potent melatonin analog in the hamster brain, possessed no potency in all preparations from different regions in the three species under investigation. The regional distribution of the receptor showed insignificant species differences. Highest density was always recorded in the median eminence/pars tuberalis (ME/PT) area. Other regions (SCN, POA and certain cortical areas), showed lower, but significant, receptor content. Saturation and competition studies revealed that these binding sites were also of high affinity, low capacity and high specificity.(ABSTRACT TRUNCATED AT 250 WORDS)
Publication Date: 1991-03-01 PubMed ID: 1645852DOI: 10.1159/000125721Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study analyses and maps the melatonin receptors found in the brains of rabbits, horses, and sheep by using an in vitro binding technique with labeled iodomelatonin. Previous studies on this topic have not included rabbits and horses. The study characterizes these receptors’ properties and distribution in different brain regions, facilitating interspecies comparison under similar methodological conditions.

Study Methodology

  • The experiment used 2-[125I]iodomelatonin, a radioactive form of iodomelatonin, as a labelled ligand to mark the melatonin receptors in the brain extracts from the three species.
  • A series of kinetic and saturation experiments were conducted to understand the binding properties of the receptors.
  • In addition, competition studies using a variety of indoles were used to measure the receptors’ binding strength and order of potency.

Key Findings

  • The binding of the labelled iodomelatonin to the melatonin receptors was found to be quick, stable, reversible, and high affinity, showing high affinity for the ligand and low capacity.
  • The competition studies demonstrated that the order of potency of different indoles used in inhibiting iodomelatonin binding was 2-iodomelatonin, followed by 6-chloromelatonin, melatonin, 5-methoxytryptophol, and then 5-methoxytryptamine, which was consistent across different brain regions in the three species.
  • Prazosin, a potent melatonin analogue reported in hamster brains, showed no potency in these three mammalian species.
  • The melatonin receptor distribution, although varies among different brain regions, was remarkably consistent across the three species, with the highest receptor density always observed in the Median Eminence/Pars Tuberalis (ME/PT) area.

Conclusion

  • The research provides valuable insights into the nature and distribution of melatonin receptors in untested species – the horse and rabbit, in addition to providing more comprehensive information about the receptor in already studied species (sheep).
  • Quantifying the order of potency of various indoles on these receptors enables better understanding of melatonin’s role and the interaction of other indoles with the receptor.
  • The consistent regional distribution of receptor sites across species suggests common functional roles for melatonin in differing mammals, although the related biological consequences are yet to be fully understood.

Cite This Article

APA
Stankov B, Cozzi B, Lucini V, Fumagalli P, Scaglione F, Fraschini F. (1991). Characterization and mapping of melatonin receptors in the brain of three mammalian species: rabbit, horse and sheep. A comparative in vitro binding study. Neuroendocrinology, 53(3), 214-221. https://doi.org/10.1159/000125721

Publication

ISSN: 0028-3835
NlmUniqueID: 0035665
Country: Switzerland
Language: English
Volume: 53
Issue: 3
Pages: 214-221

Researcher Affiliations

Stankov, B
  • Department of Pharmacology, Faculty of Sciences, University of Milan, Italy.
Cozzi, B
    Lucini, V
      Fumagalli, P
        Scaglione, F
          Fraschini, F

            MeSH Terms

            • Animals
            • Binding, Competitive
            • Brain / metabolism
            • Cerebral Cortex / metabolism
            • Horses
            • Kinetics
            • Male
            • Median Eminence / metabolism
            • Melatonin / analogs & derivatives
            • Melatonin / metabolism
            • Pituitary Gland, Anterior / metabolism
            • Preoptic Area / metabolism
            • Rabbits
            • Receptors, Melatonin
            • Receptors, Neurotransmitter / metabolism
            • Sheep
            • Suprachiasmatic Nucleus / metabolism

            Citations

            This article has been cited 11 times.
            1. Porfirio MC, Gomes de Almeida JP, Stornelli M, Giovinazzo S, Purper-Ouakil D, Masi G. Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?. Neuropsychiatr Dis Treat 2017;13:2167-2174.
              doi: 10.2147/NDT.S127564pubmed: 28860773google scholar: lookup
            2. Cavina L, van der Born D, Klaren PHM, Feiters MC, Boerman OC, Rutjes FPJT. Design of Radioiodinated Pharmaceuticals: Structural Features Affecting Metabolic Stability towards in Vivo Deiodination.. European J Org Chem 2017 Jun 30;2017(24):3387-3414.
              doi: 10.1002/ejoc.201601638pubmed: 28736501google scholar: lookup
            3. Pévet P. Melatonin.. Dialogues Clin Neurosci 2002 Mar;4(1):57-72.
              doi: 10.31887/DCNS.2002.4.1/ppevetpubmed: 22034091google scholar: lookup
            4. Pévet P. Melatonin in animal models.. Dialogues Clin Neurosci 2003 Dec;5(4):343-52.
              doi: 10.31887/DCNS.2003.5.4/ppevetpubmed: 22033558google scholar: lookup
            5. Schwartz C, Bartell P, Cassone V, Smotherman M. Distribution of 2-[I]iodomelatonin binding in the brain of Mexican free-tailed bats (Tadarida brasiliensis).. Brain Behav Evol 2009;73(1):16-25.
              doi: 10.1159/000202987pubmed: 19223684google scholar: lookup
            6. Peres MF, Sanchez del Rio M, Seabra ML, Tufik S, Abucham J, Cipolla-Neto J, Silberstein SD, Zukerman E. Hypothalamic involvement in chronic migraine.. J Neurol Neurosurg Psychiatry 2001 Dec;71(6):747-51.
              doi: 10.1136/jnnp.71.6.747pubmed: 11723194google scholar: lookup
            7. Nonno R, Pannacci M, Lucini V, Angeloni D, Fraschini F, Stankov BM. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists.. Br J Pharmacol 1999 Jul;127(5):1288-94.
              doi: 10.1038/sj.bjp.0702658pubmed: 10455277google scholar: lookup
            8. Cagnacci A, Volpe A. Influence of melatonin and photoperiod on animal and human reproduction.. J Endocrinol Invest 1996 Jun;19(6):382-411.
              doi: 10.1007/BF03344974pubmed: 8844459google scholar: lookup
            9. Fauteck JD, Bockmann J, Böckers TM, Wittkowski W, Köhling R, Lücke A, Straub H, Speckmann EJ, Tuxhorn I, Wolf P. Melatonin reduces low-Mg2+ epileptiform activity in human temporal slices.. Exp Brain Res 1995;107(2):321-5.
              doi: 10.1007/BF00230052pubmed: 8773250google scholar: lookup
            10. Merks T, Schulze-Bonhage A, Wittkowski W. Photoperiod-dependent changes in exocytotic activity in the hypophyseal pars tuberalis of the Djungarian hamster, Phodopus sungorus.. Cell Tissue Res 1993 Aug;273(2):287-91.
              doi: 10.1007/BF00312830pubmed: 8364970google scholar: lookup
            11. Hudson R, Melo AI, González-Mariscal G. Effect of photoperiod and exogenous melatonin on correlates of estrus in the domestic rabbit.. J Comp Physiol A 1994 Nov;175(5):573-9.
              doi: 10.1007/BF00199478pubmed: 7965922google scholar: lookup